Answers are grounded in this paper and cite their sources.
Review highlights flexible bioelectronics for real-time cardiac monitoring and stimulation, indicating broad therapeutic potential for arrhythmias, ischemia, and heart failure.
Soft bioelectronics is a type of innovative technology that creates electronic devices of organic or inorganic materials on flexible/ductile substrate, holding tremendous promise for the diagnosis and treatment of different diseases. The soft bioelectronic devices, when seamlessly in contact with the heart's surface, facilitate real-time monitoring of crucial parameters such as volume, pressure, and electrophysiological signals, which are indispensable for diagnosing disorders such as ischemic heart disease, arrhythmias, and heart failure. Additionally, integrating electrical and optical stimulation units into these soft bioelectronic devices could lead to significant improvements in cardiac electrophysiology. This review comprehensively covers recent progress in the development of soft bioelectronic devices for management of heart diseases, highlighting the technical challenges and future prospects in this field. • Soft bioelectronics holds tremendous potential for the diagnosis and treatment of heart diseases. • The application of soft bioelectronics in the management of heart diseases is summarized. • The technical challenges and development directions of soft bioelectronics are discussed.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: